A study on the efficacy of recombinant human endostatin combined with chemotherapy intreating advanced non-small-cell lung cancer.

CONCLUSION: This study demonstrated that CRC patients with isolated liver metastasis, <pT4 stage and curative liver metastasectomy achieved the best survival outcomes.
PMID: 31983092 [PubMed - in process]

Source: Journal of B.U.ON. - January 28, 2020 Category: Cancer & Oncology Tags: J BUON Source Type: research